For: | Li YL, Tian Z, Wu DY, Fu BY, Xin Y. Loss of heterozygosity on 10q23.3 and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions. World J Gastroenterol 2005; 11(2): 285-288 [PMID: 15633233 DOI: 10.3748/wjg.v11.i2.285] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i2/285.htm |
Number | Citing Articles |
1 |
Bryan T. Hennessy, Debra L. Smith, Prahlad T. Ram, Yiling Lu, Gordon B. Mills. Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery. Nature Reviews Drug Discovery 2005; 4(12): 988 doi: 10.1038/nrd1902
|
2 |
Mohammad Rafi Khezri, Reza Jafari, Keyvan Yousefi, Naime Majidi Zolbanin. The PI3K/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions. Experimental and Molecular Pathology 2022; 127: 104787 doi: 10.1016/j.yexmp.2022.104787
|
3 |
James W. Watters, Christopher J. Roberts. Developing gene expression signatures of pathway deregulation in tumors. Molecular Cancer Therapeutics 2006; 5(10): 2444 doi: 10.1158/1535-7163.MCT-06-0340
|
4 |
Wen-Ting Xu, Zhen Yang, Nong-Hua Lu. Roles of PTEN (Phosphatase and Tensin Homolog) in Gastric Cancer Development and Progression. Asian Pacific Journal of Cancer Prevention 2014; 15(1): 17 doi: 10.7314/APJCP.2014.15.1.17
|
5 |
Ayda Baghery Saghchy Khorasani, Atieh Pourbagheri-Sigaroodi, Ali Pirsalehi, Ava Safaroghli-azar, Mohammad Reza Zali, Davood Bashash. The PI3K/Akt/mTOR signaling pathway in gastric cancer; from oncogenic variations to the possibilities for pharmacologic interventions. European Journal of Pharmacology 2021; 898: 173983 doi: 10.1016/j.ejphar.2021.173983
|
6 |
Bence Kővári, Fátima Carneiro, Gregory Y Lauwers. Morson and Dawson's Gastrointestinal Pathology. 2024; : 227 doi: 10.1002/9781119423195.ch13
|
7 |
Lu Tang, Xintao Li, Yu Gao, Luyao Chen, Liangyou Gu, Jianwen Chen, Xiangjun Lyu, Yu Zhang, Xu Zhang, Renato Franco. Phosphatase and tensin homolog (PTEN) expression on oncologic outcome in renal cell carcinoma: A systematic review and meta-analysis. PLOS ONE 2017; 12(7): e0179437 doi: 10.1371/journal.pone.0179437
|
8 |
Laura Thomas, Victor-Felix Mautner, David N Cooper, Meena Upadhyaya. Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1. Human Genomics 2012; 6(1) doi: 10.1186/1479-7364-6-18
|
9 |
Wataru Matsunaga, Misa Ichikawa, Takahiro Ishikawa, Akinobu Gotoh. Lentiviral vector-mediated transfection of p53, p16 and PTEN genes against human renal cell carcinoma cell lines. Personalized Medicine Universe 2019; 8: 10 doi: 10.1016/j.pmu.2019.03.001
|
10 |
A. TANAKA, J. WATARI, H. TANABE, A. MAEMOTO, M. FUJIYA, T. ASHIDA, K. M. DAS, Y. KOHGO. Effect of eradication of Helicobacter pylori on genetic instabilities in gastric intestinal metaplasia. Alimentary Pharmacology & Therapeutics 2006; 24(s4): 194 doi: 10.1111/j.1365-2036.2006.00045.x
|
11 |
Adam M. Gustafson, Raffaella Soldi, Christina Anderlind, Mary Beth Scholand, Jun Qian, Xiaohui Zhang, Kendal Cooper, Darren Walker, Annette McWilliams, Gang Liu, Eva Szabo, Jerome Brody, Pierre P. Massion, Marc E. Lenburg, Stephen Lam, Andrea H. Bild, Avrum Spira. Airway PI3K Pathway Activation Is an Early and Reversible Event in Lung Cancer Development. Science Translational Medicine 2010; 2(26) doi: 10.1126/scitranslmed.3000251
|
12 |
Baoxuan Li, Yang Wang, Yue Wang, Siman Li, Kuiran Liu. Deep Infiltrating Endometriosis Malignant Invasion of Cervical Wall and Rectal Wall With Lynch Syndrome: A Rare Case Report and Review of Literature. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.832228
|
13 |
Ho-Keun Yi, Sun-Young Kim, Pyoung-Han Hwang, Chan-Young Kim, Doo-Hyun Yang, Youngman Oh, Dae-Yeol Lee. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells. Biochemical and Biophysical Research Communications 2005; 330(3): 760 doi: 10.1016/j.bbrc.2005.03.045
|
14 |
Akari Minami, Atsuko Nakanishi, Yasunori Ogura, Yasuko Kitagishi, Satoru Matsuda. Connection between Tumor Suppressor BRCA1 and PTEN in Damaged DNA Repair. Frontiers in Oncology 2014; 4 doi: 10.3389/fonc.2014.00318
|
15 |
Fereshteh Mansoury, Nahid Babaei, Soheila Abdi, Maliheh Entezari, Abbas Doosti. Evaluation of the PTEN and circRNA-CDR1as Gene Expression Changes in Gastric Cancer and Normal Cell Lines Following the Exposure to Weak and Moderate 50 Hz Electromagnetic Fields. International Journal of Cancer Management 2021; 14(4) doi: 10.5812/ijcm.111079
|
16 |
M. Moshahid Alam Rizvi, M. Shabbir Alam, Syed Jafar Mehdi, Asgar Ali, Swaraj Batra. Allelic Loss of 10q23.3, the PTEN Gene Locus in Cervical Carcinoma from Northern Indian Population. Pathology & Oncology Research 2012; 18(2): 309 doi: 10.1007/s12253-011-9446-z
|
17 |
Hasibe Cingilli Vural. PCR-SSCP-DNA Sequencing Method in DetectingPTENGene Mutation and its Significance in Human Breast Cancer in Turkish Populations. Biotechnology & Biotechnological Equipment 2012; 26(5): 3220 doi: 10.5504/BBEQ.2012.0084
|
18 |
Pixu Liu, Hailing Cheng, Thomas M. Roberts, Jean J. Zhao. Targeting the phosphoinositide 3-kinase pathway in cancer. Nature Reviews Drug Discovery 2009; 8(8): 627 doi: 10.1038/nrd2926
|
19 |
Rossella Rotondo, Flavio Rizzolio, Tiziana Perin, Massimiliano Berretta, Fabrizio Zanconati, Antonio Giordano, Vincenzo Canzonieri. Gastric Cancer In The Precision Medicine Era. Current Clinical Pathology 2019; : 53 doi: 10.1007/978-3-030-04861-7_4
|
20 |
SUNG SOO KIM, NAM JIN YOO, EUN GOO JEONG, MIN SUNG KIM, SUG HYUNG LEE. Expression of NEDD‐1, a PTEN regulator, in gastric and colorectal carcinomas . APMIS 2008; 116(9): 779 doi: 10.1111/j.1600-0463.2008.00999.x
|
21 |
Fátima Carneiro, Gregory Y. Lauwers. Morson and Dawson's Gastrointestinal Pathology. 2013; : 180 doi: 10.1002/9781118399668.ch13
|
22 |
Anna D. Panani. Cytogenetic and molecular aspects of gastric cancer: Clinical implications. Cancer Letters 2008; 266(2): 99 doi: 10.1016/j.canlet.2008.02.053
|
23 |
Hui Jun Lim, Philip Crowe, Jia-Lin Yang. Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer. Journal of Cancer Research and Clinical Oncology 2015; 141(4): 671 doi: 10.1007/s00432-014-1803-3
|
24 |
Federico Rojo, Josep Tabernero, Joan Albanell, Eric Van Cutsem, Atsushi Ohtsu, Toshihiko Doi, Wasaburo Koizumi, Kuniaki Shirao, Hiroya Takiuchi, S. Ramon Cajal, José Baselga. Pharmacodynamic Studies of Gefitinib in Tumor Biopsy Specimens From Patients With Advanced Gastric Carcinoma. Journal of Clinical Oncology 2006; 24(26): 4309 doi: 10.1200/JCO.2005.04.2424
|
25 |
Jing Li, Barry R Davies, Sufang Han, Minhua Zhou, Yu Bai, Jingchuan Zhang, Yan Xu, Lily Tang, Huiying Wang, Yuan Jie Liu, Xiaolu Yin, Qunsheng Ji, De-Hua Yu. The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere. Journal of Translational Medicine 2013; 11(1) doi: 10.1186/1479-5876-11-241
|
26 |
Asgar Ali, Syed Jafar Mehdi, Krishnan Hajela, Sundeep Singh Saluja, Pramod Kumar Mishra, Aga Syed Sameer, M. Moshahid Alam Rizvi. Allelic loss atPTENlocus leads to progression of colorectal carcinoma among North Indian patients. Biomarkers 2016; 21(8): 716 doi: 10.3109/1354750X.2016.1172115
|
27 |
Modjtaba Emadi-Baygi, Rina Sedighi, Nooshin Nourbakhsh, Parvaneh Nikpour. Pseudogenes in gastric cancer pathogenesis: a review article. Briefings in Functional Genomics 2017; 16(6): 348 doi: 10.1093/bfgp/elx004
|
28 |
Jiachi Ma, Xiaowen Sun, Yimin Wang, Bangling Chen, Liyu Qian, Yaguo Wang. Fibroblast-derived CXCL12 regulates PTEN expression and is associated with the proliferation and invasion of colon cancer cells via PI3k/Akt signaling. Cell Communication and Signaling 2019; 17(1) doi: 10.1186/s12964-019-0432-5
|
29 |
Mukesh Verma, Daniela Seminara, Fernando J. Arena, Christy John, Kumiko Iwamoto, Virginia Hartmuller. Genetic and Epigenetic Biomarkers in Cancer. Molecular Diagnosis & Therapy 2006; 10(1): 1 doi: 10.1007/BF03256438
|
30 |
Won Hyuk Choi, Sookhyun Lee, Sungjin Cho. Microsatellite Alterations and Protein Expression of 5 Major Tumor Suppressor Genes in Gastric Adenocarcinomas. Translational Oncology 2018; 11(1): 43 doi: 10.1016/j.tranon.2017.10.007
|
31 |
Yu Nakamura, Toshiro Migita, Fumie Hosoda, Naoko Okada, Masahiro Gotoh, Yasuhito Arai, Michiyo Fukushima, Misao Ohki, Satoshi Miyata, Kengo Takeuchi, Issei Imoto, Hitoshi Katai, Toshiharu Yamaguchi, Johji Inazawa, Setsuo Hirohashi, Yuichi Ishikawa, Tatsuhiro Shibata. Krüppel‐like factor 12 plays a significant role in poorly differentiated gastric cancer progression. International Journal of Cancer 2009; 125(8): 1859 doi: 10.1002/ijc.24538
|
32 |
Mukesh Verma, Upender Manne. Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populations. Critical Reviews in Oncology/Hematology 2006; 60(1): 9 doi: 10.1016/j.critrevonc.2006.04.002
|
33 |
Paraskevi Vogiatzi, Carla Vindigni, Franco Roviello, Alessandra Renieri, Antonio Giordano. Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis. Journal of Cellular Physiology 2007; 211(2): 287 doi: 10.1002/jcp.20982
|
34 |
Zhen Yang, Xiao-Gang Yuan, Jiang Chen, Shi-Wen Luo, Zhi-Jun Luo, Nong-Hua Lu. Reduced expression of PTEN and increased PTEN phosphorylation at residue Ser380 in gastric cancer tissues: A novel mechanism of PTEN inactivation. Clinics and Research in Hepatology and Gastroenterology 2013; 37(1): 72 doi: 10.1016/j.clinre.2012.03.002
|
35 |
Moon Kyung Joo, Jong-Jae Park, Hoon Jai Chun. Recent updates of precision therapy for gastric cancer: Towards optimal tailored management. World Journal of Gastroenterology 2016; 22(19): 4638-4650 doi: 10.3748/wjg.v22.i19.4638
|
36 |
Kang Li, Luobu Gesang, Chaohui He. Mechanism of apoptosis involved in gastric mucosal lesions in Tibetans with high-altitude polycythemia. Experimental and Therapeutic Medicine 2017; 14(4): 3780 doi: 10.3892/etm.2017.4996
|
37 |
A. TANAKA, J. WATARI, H. TANABE, A. MAEMOTO, M. FUJIYA, T. ASHIDA, K. M. DAS, Y. KOHGO. Effect of eradication of Helicobacter pylori on genetic instabilities in gastric intestinal metaplasia. Alimentary Pharmacology & Therapeutics Symposium Series 2006; 2(1): 194 doi: 10.1111/j.1746-6342.2006.00045.x
|
38 |
Sormeh Mina, Benjamin A Bohn, Ronald Simon, Antje Krohn, Matthias Reeh, Dirk Arnold, Carsten Bokemeyer, Guido Sauter, Jakob R Izbicki, Andreas Marx, Phillip R Stahl. PTEN deletion is rare but often homogeneous in gastric cancer. Journal of Clinical Pathology 2012; 65(8): 693 doi: 10.1136/jclinpath-2011-200525
|
39 |
SHOUJI SHIMOYAMA. Unraveling trastuzumab and lapatinib inefficiency in gastric cancer: Future steps (Review). Molecular and Clinical Oncology 2014; 2(2): 175 doi: 10.3892/mco.2013.218
|